World ADC Berlin 2018
Now in it's 8th year, World ADC Berlin is Europe's leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.
Attend World ADC Berlin next year to validate novel ADC targets, improve understanding of mechanisms driving toxicity in clinical development and robustly scale up process development to support commercialisation. For 2018, 320 drug developers across 140 active organisations will unite at this industry focussed conference to foster new connections, further develop business relationships and meet with current partners.
Join your peers at Europe's longest standing and most comprehensive ADC conference to power the development of your ADC pipeline.